BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 26368127)

  • 1. Pro-Oxidant Activity of Amine-Pyridine-Based Iron Complexes Efficiently Kills Cancer and Cancer Stem-Like Cells.
    González-Bártulos M; Aceves-Luquero C; Qualai J; Cussó O; Martínez MA; Fernández de Mattos S; Menéndez JA; Villalonga P; Costas M; Ribas X; Massaguer A
    PLoS One; 2015; 10(9):e0137800. PubMed ID: 26368127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly cytotoxic iron(II) complexes with pentadentate pyridyl ligands as a new class of anti-tumor agents.
    Wong EL; Fang GS; Che CM; Zhu N
    Chem Commun (Camb); 2005 Sep; (36):4578-80. PubMed ID: 16158120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alkyl substituted 2'-benzoylpyridine thiosemicarbazone chelators with potent and selective anti-neoplastic activity: novel ligands that limit methemoglobin formation.
    Stefani C; Jansson PJ; Gutierrez E; Bernhardt PV; Richardson DR; Kalinowski DS
    J Med Chem; 2013 Jan; 56(1):357-70. PubMed ID: 23276209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and characterization of novel iron chelators: structure-activity relationships of the 2-benzoylpyridine thiosemicarbazone series and their 3-nitrobenzoyl analogues as potent antitumor agents.
    Kalinowski DS; Yu Y; Sharpe PC; Islam M; Liao YT; Lovejoy DB; Kumar N; Bernhardt PV; Richardson DR
    J Med Chem; 2007 Jul; 50(15):3716-29. PubMed ID: 17602603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Acetylpyridine thiosemicarbazones are potent iron chelators and antiproliferative agents: redox activity, iron complexation and characterization of their antitumor activity.
    Richardson DR; Kalinowski DS; Richardson V; Sharpe PC; Lovejoy DB; Islam M; Bernhardt PV
    J Med Chem; 2009 Mar; 52(5):1459-70. PubMed ID: 19216562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of novel coumarin nucleus-based DPA drug-like molecular entity: In vitro DNA/Cu(II) binding, DNA cleavage and pro-oxidant mechanism for anticancer action.
    Khan S; Malla AM; Zafar A; Naseem I
    PLoS One; 2017; 12(8):e0181783. PubMed ID: 28763458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Halogenated 2'-benzoylpyridine thiosemicarbazone (XBpT) chelators with potent and selective anti-neoplastic activity: relationship to intracellular redox activity.
    Stefani C; Punnia-Moorthy G; Lovejoy DB; Jansson PJ; Kalinowski DS; Sharpe PC; Bernhardt PV; Richardson DR
    J Med Chem; 2011 Oct; 54(19):6936-48. PubMed ID: 21846118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?
    Matos CP; Adiguzel Z; Yildizhan Y; Cevatemre B; Onder TB; Cevik O; Nunes P; Ferreira LP; Carvalho MD; Campos DL; Pavan FR; Pessoa JC; Garcia MH; Tomaz AI; Correia I; Acilan C
    Eur J Med Chem; 2019 Aug; 176():492-512. PubMed ID: 31132480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis and Antiproliferative Activities of Oxidative Stress Inducers Based on 2-Styryl-3,5-dihydro-4H-imidazol-4-one Scaffold.
    Omar AM; Abdelghany TM; Abdel-Bakky MS; Alahdal AM; Radwan MF; El-Araby ME
    Chem Pharm Bull (Tokyo); 2018 Oct; 66(10):967-975. PubMed ID: 30047515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The variable chemotherapeutic response of Malabaricone-A in leukemic and solid tumor cell lines depends on the degree of redox imbalance.
    Manna A; De Sarkar S; De S; Bauri AK; Chattopadhyay S; Chatterjee M
    Phytomedicine; 2015 Jul; 22(7-8):713-23. PubMed ID: 26141757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological Evaluation of Ferrocenyl Olefins: Cancer Cell Growth Inhibition, ROS Production, and Apoptosis Activity.
    Sun A; Lin J; Pi C; Xu R; Cui X
    Arch Pharm (Weinheim); 2016 Mar; 349(3):186-92. PubMed ID: 26841261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly Charged, Cytotoxic, Cyclometalated Iridium(III) Complexes as Cancer Stem Cell Mitochondriotropics.
    Laws K; Eskandari A; Lu C; Suntharalingam K
    Chemistry; 2018 Oct; 24(57):15205-15210. PubMed ID: 30052298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoferrocene-based prodrugs activated by reactive oxygen species.
    Hagen H; Marzenell P; Jentzsch E; Wenz F; Veldwijk MR; Mokhir A
    J Med Chem; 2012 Jan; 55(2):924-34. PubMed ID: 22185340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron chelation with salicylaldehyde isonicotinoyl hydrazone protects against catecholamine autoxidation and cardiotoxicity.
    Hašková P; Kovaříková P; Koubková L; Vávrová A; Macková E; Simůnek T
    Free Radic Biol Med; 2011 Feb; 50(4):537-49. PubMed ID: 21147217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterobimetallic Ru(ii)/Fe(ii) complexes as potent anticancer agents against breast cancer cells, inducing apoptosis through multiple targets.
    Guedes APM; Mello-Andrade F; Pires WC; de Sousa MAM; da Silva PFF; de Camargo MS; Gemeiner H; Amauri MA; Gomes Cardoso C; de Melo Reis PR; Silveira-Lacerda EP; Batista AA
    Metallomics; 2020 Apr; 12(4):547-561. PubMed ID: 32108850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in iron-complexes as drug candidates for cancer therapy: reactivity, mechanism of action and metabolites.
    Bouché M; Hognon C; Grandemange S; Monari A; Gros PC
    Dalton Trans; 2020 Aug; 49(33):11451-11466. PubMed ID: 32776052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the cytotoxic activity of new phenanthroline salicylaldimine Zn(II) complexes.
    Matos CP; Addis Y; Nunes P; Barroso S; Alho I; Martins M; Matos APA; Marques F; Cavaco I; Costa Pessoa J; Correia I
    J Inorg Biochem; 2019 Sep; 198():110727. PubMed ID: 31195153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-activating nuclease and anticancer activities of copper(II) complexes with aryl-modified 2,6-di(thiazol-2-yl)pyridine.
    Li L; Du K; Wang Y; Jia H; Hou X; Chao H; Ji L
    Dalton Trans; 2013 Aug; 42(32):11576-88. PubMed ID: 23843095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diorganotin (IV) complexes with 4-nitro-N-phthaloyl-glycine: Synthesis, characterization, antitumor activity and DNA-binding studies.
    Yan C; Zhang J; Liang T; Li Q
    Biomed Pharmacother; 2015 Apr; 71():119-27. PubMed ID: 25960226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor properties and mechanisms of mitochondria-targeted Ag(I) and Au(I) complexes containing N-heterocyclic carbenes derived from cyclophanes.
    Li Y; Liu GF; Tan CP; Ji LN; Mao ZW
    Metallomics; 2014 Aug; 6(8):1460-8. PubMed ID: 24788133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.